BioSpace News Archive

Surge in prevalence of chronic injuries around the globe is expected to boost the expansion prospects in the global advance wound care market in the forecast period of 2021 to 2031.

Since the last decade, technologies and techniques for rapid sequencing of human genomes have made incredible strides.

InnoCare Pharma, a leading biotech company, announced that the company will present latest data of its BTK inhibitor orelabrutinib at the 63rd American Society of Hematology Annual Meeting on December 11-14, 2021, which will be hold online and offline in Atlanta, Georgia.

ERYTECH Pharma announced that its CEO, Gil Beyen, will participate in a fireside chat at the 12th Annual Jefferies London Healthcare Conferenceand invites investors to participate in one-on-one meetings both in-person on Tuesday and Wednesday, November 16th/17th or virtually on Thursday and Friday, November 18th/19th.

Biognosys, a leader in proteomics solutions for drug discovery and development, announces the launch of its next-generation blood biomarker discovery solution, which will be offered as a contract research service.

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the Company”), a global leader in innovations for active healing, today reported financial results for three and nine months ended October 2, 2021.

Plus Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track designation for Rhenium-186 NanoLiposome ( 186 RNL)

Oyster Point Pharma, Inc. today announced multiple scientific presentations at the American Academy of Ophthalmology (AAO) Annual Meeting 2021 being held in New Orleans, LA November 12th – 15th , 2021.

Tonix Pharmaceuticals Holding Corp. today announced a poster presentation of results from its open-label, Phase 1 clinical study of TNX-601 CR (tianeptine oxalate and naloxone controlled-release tablets).

Sigilon Therapeutics, Inc. today announced that its President and Chief Executive Officer, Rogerio Vivaldi, M.D., will participate in a fireside chat during the upcoming Jefferies London Healthcare Conference.